FDA | ZP Perspectives
Posted in Covid19, FDA, PPE
Recently released surveys of nurses and dentists illustrate health care providers continued inability to quickly procure certified and authentic personal protective equipment. (PPE). A survey of more than 1,000 dental practices released earlier in May found that 90% of those surveyed were concerned about procuring PPE. A survey of over 23,000 nurses found that 87%…
By mfischer on June 11, 2020
Posted in Covid19, FDA
As the COVID-19 pandemic continues, so have regulatory actions by the U.S. Food and Drug Administration (FDA) affecting the regenerative medicine industry. This includes the issuance of agency demand letters also known as “warning” letters that are served on parties for alleged violations of federal law. Historically, such actions were not rendered until an in-person…